Vanderbilt Institute for Infection Immunology and Inflammation

January 29, 2024

Expanded space boosts cutting-edge research in infectious diseases and immunology

The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.

By Leigh MacMillan
January 16, 2024

‘Molecular Muse’ exhibit features Artist-in-Residence program’s science-inspired art

The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool.

By Leigh MacMillan
December 19, 2023

Three from VUMC elected to ASCI

Three physician scientists from Vanderbilt University Medical Center have been elected this year to membership in the American Society for Clinical Investigation, one of the nation’s oldest and most respected medical honor societies.

By Bill Snyder
Sage Davis, 4, observes microbial “snakes” and “space bears” (tardigrades) under the microscope with his parents, Corinne and Gerald.
September 29, 2023

Educational event zooms in on complex world of microbes

More than 100 children and their families attended the sixth annual MEGAMicrobe community science recently at Gower Elementary School in Nashville.

By Bill Snyder
Children had a field day on Oct. 19 exploring with Vanderbilt scientists the “great big world of tiny microbes” — bacteria, viruses and other germs. The third annual MEGAMicrobe event, hosted by the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4), was held at Granbery Elementary School in Brentwood. MEGAMicrobe’s goal is to make science fun and accessible. For more information, go here.
August 23, 2023

Free MEGAMicrobe interactive event set for Sept. 23

MEGAMicrobe, a free exploration of the world of microbes, will be held from 10 a.m. to 2 p.m. Saturday, Sept. 23, at Gower Elementary School.

By Bill Snyder
July 28, 2023

VI4 Artist-in-Residence exhibition opens Aug. 7

The Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence Program (VI4-AiR) invites the public to the opening celebration of its “Molecular Muse” exhibition Aug. 7 at the Vanderbilt Fine Arts Gallery.

By Anthony Czelusniak
April 20, 2023

Study details RNA editing in virus-infected cancer cells

Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection.
By Leigh MacMillan
March 30, 2023

NIH grant launches C. diff vaccine research initiative

Vanderbilt has received an NIH grant to launch the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines, or VANDy-CdV.
By Anthony Czelusniak
March 23, 2023

Mathers Foundation award supports study of bacterial physiology

Vanderbilt's Wenhan Zhu, PhD, has received a three-year award from the G. Harold and Leila Y. Mathers Foundation to support his research that aims to answer a fundamental question about bacterial physiology and engineer probiotics to improve gut inflammatory diseases.
By Leigh MacMillan
March 23, 2023

E. coli uses serine to abide acidity

Vanderbilt researchers have discovered another acid resistance mechanism for UTI-causing E. coli, laying the foundation for targeted antibacterial therapies.
By Cherie Saffold
February 20, 2023

Probing hellbender health

Understanding how hellbenders — large, fully aquatic salamanders — fight fungal pathogens and disease is important for protecting these unique stream predators; Vanderbilt researchers add new insights.
By Leigh MacMillan
January 13, 2023

Study identifies potential new approach for treating lupus

A Vanderbilt study found that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus — the most common form of the chronic autoimmune disease lupus.
By Leigh MacMillan
September 29, 2022

VUMC lands grant to build top-line biosafety facility

Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.
By Bill Snyder
1 2 3 … 5